Simple research view

TMO · Thermo Fisher Scientific Inc

$684.89 +1.64% Oct 26 close

Detected setup Cup & Handle · Setup Score 70/100

Stand aside — setup invalidated

Setup score 70, but distribution days reach 5 or more — stand aside until the condition resets.

2 independent risk warnings also present. Review before relying on the bullish setup.

Ask about TMO

Switch to Advanced for indicator panels, raw grades, provenance, drawing tools, and full technical tables.

$TMO

Thermo Fisher Scientific Inc

Thermo Fisher Scientific Inc is a mega-cap Medical Specialties company in the Health Technology sector with a market cap of $253B.

Health Technology Medical Specialties stock Stage 2 · Advancing Base 1

$684.89 latest close

⚠ Risk Signals

Bearish RSI Divergence Price higher high ($679.61→$696.49) but RSI lower high (74→67) — momentum diverging

Bearish MACD Divergence Price higher high ($679.61→$696.49) but MACD lower high (20.83→12.93) — momentum diverging

Bearish structure on the daily chart — a heads-up for anyone holding, not a short signal. Does not affect the bullish setup score.

Market Structure

Trend structure: uptrend

Latest event: bos (bullish)

Support 493.37–495.04 · 4 touches · moderate

Support 455.60–458.34 · 3 touches · moderate

Support 577.00–580.00 · 3 touches · moderate

Support 598.52–602.32 · 3 touches · moderate

Momentum Turn Watch

Bollinger Squeeze Bollinger band width (8.4%) is in the bottom quartile of its last 120 sessions — Legend's width-percentile squeeze (not a TTM/Keltner squeeze), so volatility is compressed and a sharper move often follows.

Early technical context only. Wait for price, volume, and the canonical setup trigger to confirm; this signal does not change readiness or the setup score.

Join to Watchlist $TMO Share card

Verdict · setup score 70/100 · data Oct 26 close · latest session

Stand aside — setup invalidated

Setup score 70, but distribution days reach 5 or more — stand aside until the condition resets.

Review six verdicts Inspect chart

Recent price action · daily

What would change this verdict

What needs to turn for this to become buyable — the top failing checks across the legend council:

Minervini 2. Quarterly EPS growth ≥ 25% — +10.8% QoQ
Minervini 2. ROE ≥ 17% — ROE 13.3%
O'Neil C: Quarterly EPS acceleration ≥ 25% — +10.8% QoQ
O'Neil A: Annual earnings & revenue quality — Rev +3.9% | ROE 13.3%
Weinstein Volume expansion above average — Volume ratio 0.88x
Weinstein Weekly price coiling (Stage 2 consolidation) — Tightening weekly range confirms base

Minority view — the council disagrees here

Minervini: watch Trend-template read: 9/12 pass; wait for the soft misses to improve.
O'Neil: avoid CANSLIM read: fails C: Quarterly EPS acceleration ≥ 25%.
Weinstein: watch Stage-analysis read: Stage 2 is present; 2 supporting checks need improvement.

71 Strong

Legend Score · rates the stock Strong (71/100) — held back by eps growth

Our proprietary 0-100 rating — the answer to Wall Street's black-box scores. Five pillars, each computed from real scan data, each explained below in plain English.

Relative Strength (25%) 84
Trend Template (25%) 100
Institutional Footprint (20%) 70
EPS Growth (15%) 30
Quality (SMR-like) (15%) 44

RS rank 83: beating most of the market. Trend template 8/8: price above rising 50/150/200-day lines — textbook uptrend structure. Institutional score 70: mild accumulation. EPS up +0% — growing, but below the 25% leadership bar. Quality 44: weak fundamentals (sales growth 30, return on equity 40, leverage 100). Updated 2026-10-27.

Earnings

Pre-earnings setup

Next earnings Wednesday, October 28, 2026 Before market open Exact clock time not supplied by source

Ordinary position sizing suppressed. Earnings are less than three full trading sessions away; treat the gap as event risk, not ordinary stop-distance risk.

Deterministic evidence

TMO+1.64%

Sector proxy · XLV+0.00%

Broad market · SPY+0.71%

Same completed session window ending 2026-10-26. TMO was +1.64 points vs XLV. +0.93 points vs SPY.

CatalystPending Stock reactionPositive Sector reactionWeak Opening surgePending Event riskEarnings-driven

Session internals Strong momentum

Rule: closed up, at or above the open, in the top third of the day's range. Judged on internals, not on the size of the move.

Vs prior close+1.64% From the open+1.15% Range position95% GapNo gap

QQQ confirmationConfirming (+1.11%) SMH confirmationConfirming (+2.74%)

Short-term conviction -1 points.

A sourced earnings report is still pending inside the risk window; ordinary technical conviction is reduced until it is out.

Price bars, sourced event fields, and benchmark math only. This can adjust displayed short-term conviction; it does not change the stored scanner score or readiness.

Ask a Legend to interpret this evidence → Commentary only — never scanner evidence or a sizing recommendation.

Price $684.89 +1.6% Oct 26 close

52W High $705.78 3.0% below high

Wks Since High 0w

Base Depth 6.3%

RS Rank 65 percentile of scan

SMA 50 $646.89

Avg Vol 2,203,401

Rel Vol (Oct 26) 0.88× 1.77× on up days

More stats

52W Low $435.27

Tight Wks 0

Base B1

SMA 200 $549.67

RS Line vs High -3.6%

RS Line Slope +0.6% ▲

Group Rank #20/66

ADR% 3.0%

ATR(14) $20.71 (3.0%)

Vol Pace (live) N/A

A/D Days 16A / 8D

A/D Rating A+

VDU Bars 0/10 d

Power Trend 12d

Earnings tomorrow

Position in 52-week range 92ndpercentile of the 52-week range

$435.27low

$705.78high

TMO Chart

Interactive price, volume, RS, RSI, and MACD charts are available after sign in.

Create a free account to load the full interactive chart for TMO.

Create Free Account

Technical Analysis Report Card

$TMO · $684.89 · as of 2026-10-26 · multi-factor read

/ 100

Technicals 98/100

Reference read from price & volume only — the verdict at the top of the page decides the action.

Trend · Daily / Weekly / Monthly

Daily ▲ Uptrend

Weekly ▲ Uptrend

Monthly ▲ Uptrend

Moving Averages

50-day$646.89 ↑

100-day$587.84 ↑

200-day$549.67 ↑

Bullish (50 > 200)

RSI (14)

Reading57.8 · Bullish

Bullish momentum — comfortably in buyer territory.

MACD (12/26/9)

StateWeakening

Histogram-1.122

Weakening — MACD slipped below its signal line. Histogram expanding.

Bollinger Bands (20,2)

%B / Width72% · 8.4%

Squeeze — volatility compressing

Mid-band — no directional band edge in play. Bands are squeezing — volatility is compressing, often a precursor to a sharp move.

Volume · Buyer vs Seller

Up/Down vol1.77 · Accumulation

Rel volume0.88×

Pocket pivots · 10d3

5d vs 50d vol148%

Heavy vol up / down3 / 1

Accumulation — volume is concentrated on up days; buyers dominate. Recent volume is expanding versus its baseline.

Pocket pivot 3 sessions ago — up-day volume beat every down day of the prior 10 sessions.
3 heavy-volume up days vs 1 down in the last 20 sessions.

Support & Resistance

R · $694.33swing level

R · $705.7852-week high

Price · $684.89now

S · $635.32swing level

S · $594.82swing level

S · $580.00swing level

Fibonacci · Uptrend swing

23.6%$641.94

38.2%$602.45

50.0%$570.52

61.8%$538.60

78.6%$493.16

Retracement support zones measured from the recent swing low up to the high.

The verdict is free. The trade plan is Pro.

Unlock the exact entry, stop-loss, profit target, and reward-to-risk for TMO — plus the full 500+ symbol scanner and Ask-the-Legends chat.

Start your 7-day free trial →

Daily uptrendWeekly uptrendMonthly uptrendAbove 200-day MA50/200 bullishVolume accumulation

Want this read in a legend's voice? Ask a Legend about TMO

Generic technical analysis generated mechanically from price & volume — educational research only, not financial advice or a personalized recommendation. Levels are illustrative; confirm on your own chart. New to these terms? →

Legend Verdicts 6 methodology checks

Who would consider this setup, why it qualifies, and what blocks it — calculated from the same deterministic methodology rules used across Legend AI.
How to read the numbers: the setup score (70/100, in the verdict band) rates this trade setup. Each legend's A–D grade rates the same setup against that legend's own checklist — so a high score next to a C grade is not a contradiction. The setup can be strong without fitting that legend's style. When the council disagrees, the verdict band breaks the tie.

Council consensus: 8 of 9 legends are Watching — building, not yet a confirmed buy.

Minervini Watch B Trend-template read: 9/12 pass; wait for the soft misses to improve.

mediumEnter on break of $695.02 pivot with stop at $663.96 (risk 4.5%). SEPA Grade B (4/7).

Passing evidence

1.1 Price > 150-day MA AND 200-day MAPrice $684.89, MA150 $551.94, MA200 $549.67

1.2 150-day MA > 200-day MAMA150 $551.94 vs MA200 $549.67

Failing evidence

2. Quarterly EPS growth ≥ 25%+10.8% QoQ

2. ROE ≥ 17%ROE 13.3%

9/12 checks

Method → Playbook → Ask →

O'Neil Avoid D CANSLIM read: fails C: Quarterly EPS acceleration ≥ 25%.

partialRule check says AVOID (3/8 checks passed) — CANSLIM read: fails C: Quarterly EPS acceleration ≥ 25%.

Passing evidence

L: RS rank ≥ 80 (IBD leadership)RS rank 83

N: Near 52-week high or RS line new high3.0% below high | RS line new high: False

Failing evidence

C: Quarterly EPS acceleration ≥ 25%+10.8% QoQ

A: Annual earnings & revenue qualityRev +3.9% | ROE 13.3%

3/8 checks

Method → Playbook → Ask →

Weinstein Watch C Stage-analysis read: Stage 2 is present; 2 supporting checks need improvement.

mediumClassic Stage 2 advancing phase — strong weekly trend confirms uptrend. This is Weinstein's sweet spot: buy and hold while price remains above the 30-week MA.

Passing evidence

Stage 2 (Advancing phase) confirmedStage 2 (Advancing)

Price above 30-week MA (200-day proxy)Price $684.89 vs MA200 $549.67

Failing evidence

Volume expansion above averageVolume ratio 0.88x

Weekly price coiling (Stage 2 consolidation)Tightening weekly range confirms base

5/7 checks

Method → Playbook → Ask →

dennis Watch C Turtle read: no breakout yet. Price is pressing the 20-day high. The system waits for the print; it never anticipates.

Passing evidence

No breakdown below the 20-day channel20-day low $635.32

Volatility-unit sizing (1N ≈ 1% of equity)1N = $19.18 (2.80% of price); the Turtles size 1 unit so a 1N move ≈ 1% of equity, making the 2N stop ≈ 2% equity risk

Failing evidence

S1: 20-day Donchian breakoutNot confirmed

S2: 55-day Donchian breakoutNot confirmed

5/7 checks

Method → Playbook → Ask →

zanger Watch B Zanger read: the structure is fine but the breakout quality is not there yet — wait for 150%+ volume on the break.

partialZanger would buy the Cup & Handle breakout only with 150-200% volume, never more than 5% above the breakout point, with a 2-3% stop set at entry. His edge over O'Neil is the exit plan: sell 20-30% of the position at +15-20%, then trail the rest on the 10/20-day moving average.

Passing evidence

Named Zanger pattern onlyCup & Handle

Not extended (≤5% above the breakout point)Measured as passing

Failing evidence

Breakout volume 1.5-2.0x averageData unavailable

5/6 checks

Method → Playbook → Ask →

zweig Watch D Zweig read: part of his screen passes but not all: EPS growth above the market (≥15% QoQ); Reasonable price for the growth (P/E ≤ 35); Insider buying — wait for the full growth screen before treating this as a Zweig setup.

Passing evidence

Price strength (RS ≥ 70)RS score 83 — Zweig buys strength, not bargains

Breadth momentum: 10-day A/D ratio10-day A/D 1.17 (1995 adv / 1699 dec) — participation expanding

Failing evidence

EPS growth above the market (≥15% QoQ)+10.8% QoQ — Zweig wants growth above the S&P average

Reasonable price for the growth (P/E ≤ 35)Trailing P/E 38.6x — no PEG or forward P/E stored

3/8 checks

Method → Playbook → Ask →

Livermore Watch B Pivotal-point read: constructive evidence is present, but volume vs average is unresolved.

Passing evidence

Price$684.89

Relative strengthRS 83

Failing evidence

Volume vs average0.88x

Pivotal point cleared on expanding volumeNot confirmed

4/6 checks

Method → Playbook → Ask →

Darvas Watch B Box-theory read: constructive evidence is present, but volume vs average is unresolved.

mediumStock is at the top of its box — Darvas would wait for a decisive breakout on volume.

Passing evidence

Price$684.89

Relative strengthRS 83

Failing evidence

Volume vs average0.88x

Box top broken on heavy volumeNot confirmed

4/6 checks

Method → Playbook → Ask →

Wyckoff Watch B Supply-and-demand read: constructive evidence is present, but volume vs average is unresolved.

Passing evidence

Price$684.89

Relative strengthRS 83

Failing evidence

Volume vs average0.88x

Sign of Strength confirmed on expanding volumePrice hasn't cleared the pivot yet — confirmation pending

4/6 checks

Method → Playbook → Ask →

Base & Breakout

Breakout follow-through

No active breakout tracked — Legend AI monitors daily for pivot-point breaks. What's a breakout?

Unlock Base & Breakout Tracking

RS Line vs SPY 52-week relative strength · blue = RS line · dashed = MA50 · dot = NH ▲ Rising

Accumulation / Distribution last 65 sessions · green = acc on high vol · red = dist on high vol Net +9 A+

Minervini · Grade Card

Fundamentals & leadership quality — Minervini’s published criteria · 4/7 met

B 4/7 criteria

Separate score from the Minervini Trend Template (8/8): the Trend Template grades the price structure, this grades the company & leadership (earnings, sales, margins, RS rank). A stock can ride a clean trend while its fundamentals lag, so the two often differ by design — they are not the same checklist.

✗ EPS acceleration ≥25% QoQ +11%

✗ Revenue growth ≥20% YoY +4%

✓ Gross margin ≥30% 41%

✗ ROE ≥17% 13%

✓ RS rating ≥80 (leadership) 83

✓ Stage 2 uptrend (Weinstein) Stage 2

✓ Within 25% of 52W high -3.0%

Method Playbook

Trade it like Zweig EXACT LEVELS · PRO

Minervini O'Neil Livermore Weinstein Darvas Wyckoff

Zweig D · Watch — The deterministic methodology check is Watch; wait for the failing or incomplete criteria to improve before the trigger can qualify.

Pivot

Pro level

Published-method rule: Use the stock's recent consolidation high — Zweig buys strength in screened growers, not breakdowns.
Evidence: Canonical setup geometry is available with Pro.

Entry trigger

Pro level

Published-method rule: Buy only when the growth screen passes: EPS growth above the market, PEG ≤ 1.5 (reasonable for the growth), insider buying, and RS leadership.
Evidence: Canonical setup geometry is available with Pro.

Initial stop

Pro level

Published-method rule: Define the loss before entry — Zweig's risk rule. Sell when the growth story breaks: earnings decelerate or the valuation stretches past reason.
Evidence: Canonical setup geometry is available with Pro.

Trail

Rule-based

Published-method rule: Hold winners as long as earnings keep growing and the price holds its trend; sell half on a climax run.
Evidence: Planned management rule; no stored stop or broker order is changed automatically.

Exit / invalidation

Pro level

Published-method rule: Exit when EPS growth falls below the market, the PEG stretches past reason, insiders stop buying — or the Super Model flips the market to defensive.
Evidence: Canonical setup geometry is available with Pro.

Deterministic educational plan, not a recommendation. No order or stop is changed automatically. Method and sources →

The published-method workflow is public. Unlock exact pivot, entry, stop, target, and sizing with Pro →

Pattern Analysis

Cup & Handle ⚠ Volatility widening into breakout ⚠ Bearish RSI divergence

70 setup score

RS Score 83

Trend template 8/8 ✓

CANSLIM 74.8* (B)

31.0% cup depth 5.4% handle rims outside 10% ideal 8 sessions since breakout

Cup 31.0% deep from a $630.44 left rim to a $435.27 low
Rims 10.1% apart (accepted, but outside the 10% ideal)
Handle pulled back 5.4% over 1 bar from $671.66 to $635.32
Handle sits in the upper half of the cup
Rounded U-shaped bottom
Pivot $694.33 fixed at the handle high
Breakout: 8 bars since the first close above the pivot
Handle volume did not dry up

Raw detector evidence · confidence is a heuristic match score, not a probability

depth=31.0%, handle_pb=5.4%, lips_diff=10.1%, upper_half=yes, u_shape=yes, near_pivot=yes, orderly=yes | Strong trend (8/8) | Top RS (83) | High-confidence pattern (72%) | Accumulation (1.8× up/dn vol) | Power Trend | Stage 2 | Readiness 71/100 (watch) | CANSLIM 74.8 (B) | ⚠ Volatility widening into breakout; Bearish RSI divergence
setup_key=cup_handle|2026-05-18|2026-10-06|694.33 · cup_handle/2026-10-03
anchors={"bottom": {"bar": 98, "bars_ago": 111, "date": "2026-05-18", "price": 435.27}, "breakout": {"bar": 202, "bars_ago": 7, "date": "2026-10-15", "price": 696.49}, "handle_high": {"bar": 196, "bars_ago": 13, "date": "2026-10-07", "price": 671.66}, "handle_low": {"bar": 197, "bars_ago": 12, "date": "2026-10-08", "price": 635.32}, "left_lip": {"bar": 14, "bars_ago": 195, "date": "2026-01-15", "price": 630.437}, "right_lip": {"bar": 195, "bars_ago": 14, "date": "2026-10-06", "price": 694.33}}

Why This Setup? D+W Confluence

Cup & Handle · schematic

Wyckoff SOS ⚠ Volatility widening into breakout ⚠ Extended past buy zone ⚠ Not actionable yet

55 setup score

RS Score 83

Trend template 8/8 ✓

CANSLIM 70.8* (B)

range low: 454.781 range high: 593.193 range pct: 0.304 sos thrust: 0.17 sos vol ratio: 1.794 sos bars ago: 3 near lps: ✗ validation reason: valid generic setup multi tf evaluated: ✓ multi tf reason: weekly: MA stabilizing or rising — accumulation context supported

Why This Setup? D+W Confluence

Wyckoff SOS · schematic

The Universal Edge Check · context only

What the setup still has going for it, recorded for later. The verdict above stands — these principles do not overrule it.

4/7 universals met

Clear of earnings — not met in 1 days — event risk
A relative-strength leader — partly met RS rank 65 — middling
Volume confirms — partly met 0.9× average — light
Asymmetric reward — met Met — levels are a Pro detail
In a confirmed uptrend — met Stage 2 · Trend template 8/8
Not chasing (in range) — met Met — levels are a Pro detail
Risk is defined — met Met — levels are a Pro detail

Why these seven? → The Universal Edge

Minervini Trend Template

8/8 ✓

Grades the price structure — moving-average stacking, distance from the 52-week high/low, and relative strength above the ≥70 uptrend bar. This is the technical trend check; the company's fundamentals and ≥80 RS leadership are scored separately in the Grade Card.

Price above SMA 150 & 200 $684.89 vs SMA150 $551.94 / SMA200 $549.67

SMA 150 above SMA 200 SMA150 $551.94 vs SMA200 $549.67

SMA 200 trending up Slope +8.86 over 20 days

SMA 50 above SMA 150 & 200 SMA50 $646.89

Price above SMA 50 $684.89 vs SMA50 $646.89

30%+ above 52-week low +57.3% from $435.27

Within 25% of 52-week high -3.0% from $705.78

RS score above 70 RS 83

Fundamentals

52W Range

92%

Mkt Cap SEC

253.2B

EPS QoQ

+11%

Rev YoY

+4%

ROE

13%

Gross Margin

41%

D/E

0.74

EPS TTM

$17.74

P/E TTM

38.6x

Float

370M

Insider

No Buy

Company

Company profile

Thermo Fisher Scientific Inc

TMO · NYSE · Health Technology · Medical Specialties

O'Neil · Grade Card

CANSLIM — current EPS, annual EPS, new highs, supply, leader RS, inst. sponsorship, market

B 74.8* CANSLIM * disqualified on C, M

C · Curr. EPS

A · Annual EPS

N · New Highs

100

S · Supply/Demand

L · Leader RS

I · Inst. Spons.

100

M · Market

Weekly Context

Multi-timeframe signals from weekly bars

W. Trend

8/8

W. RS

W. Support

$435.27

W. Resist

$705.78

W. Patterns

Cup & Handle

Weekly Structure

Trend Neutral

Tight Weeks 0

Confirmation Neutral

Scan History

20× streak

Oct 27

Cup & Handle ✓ Gate

Oct 26

Cup & Handle ✓ Gate

55 0.0%

Oct 23

Pocket Pivot ✓ Gate

92 +1.6%

Oct 23

Cup & Handle ✓ Gate

70 +1.6%

Latest News

Headlines for TMO

Loading headlines…

Get the full picture on TMO

Pro members see entry/stop/target levels, R:R ratios, intraday alerts, and every setup detected across 500+ symbols daily.

Start 7-Day Free Trial